LONDON--(BUSINESS WIRE)--The ventricular assist devices market is poised to grow by USD 943.27 million during 2020-2024, progressing at a CAGR of almost 12% during the forecast period. Request free sample pages
Read the 145-page report with TOC on "Ventricular Assist Devices Market Analysis Report by Product (left and right ventricular assist devices and bi-ventricular assist devices) and Geographic Landscape (Asia, Europe, North America, and ROW), and the Segment Forecasts, 2020-2024".
The market is driven by the rise in number of heart failure. In addition, the development of next-generation ventricular assist devices with enhanced hemocompatibility and durability is anticipated to boost the growth of the ventricular assist devices market.
Patients who suffer from chronic cardiovascular diseases have high risk of heart failure. Ischemic heart disease is one of the most common causes of heart failure. Surgeons use implantable mechanical pumps such as ventricular assist devices in patients with heart failure or those with a weak heart muscle. In addition, the implantation of ventricular assist devices is also recommended for patients with congestive heart failure. Thus, the increasing prevalence of heart failure is expected to drive market growth during the forecast period.
Buy 1 Technavio report and get the second for 50% off. Buy 2 Technavio reports and get the third for free.
Major Five Ventricular Assist Devices Companies:
Abbott Laboratories is headquartered in the US and operates the business under various segments such as Established Pharmaceuticals, Nutritionals, Diagnostics, and Cardiovascular and Neuromodulation. The company offers a left ventricular assist device, HeartMate 3 LVAD.
Abiomed Inc. is headquartered in the US and offers products through an unified business segment. The company offers Impella 2.5 and Impella RP to various end-user industries including hospitals, clinics, and ASCs.
Asahi Kasei Corp.
Asahi Kasei Corp. is headquartered in Japan and operates under various business segments, namely Material, Homes, and Health Care. The company offers an implantable left ventricular assist system, Evaheart LVAS.
Berlin Heart GmbH
Berlin Heart GmbH is headquartered in Germany and offers products through an unified business segment. The company offers a mechanical paracorporeal ventricular assist device, EXCOR Adult to various end-user industries including hospitals, clinics, and ASCs.
CorWave SA is headquartered in France and offers products through an unified business segment. The company offers a next-generation left ventricular assist device, Neptune to various end-user industries including hospitals, clinics, and ASCs.
Register for a free trial today and gain instant access to 17,000+ market research reports.
Ventricular Assist Devices Market Product Outlook (Revenue, USD mn, 2020-2024)
- Left and right ventricular assist devices
- Bi-ventricular assist devices
Ventricular Assist Devices Market Geographic Outlook (Revenue, USD mn, 2020-2024)
- North America
- Key leading countries
Technavio’s sample reports are free of charge and contain multiple sections of the report, such as the market size and forecast, drivers, challenges, trends, and more. Request a free sample report
Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.